Stereotactic radiotherapy in the treatment of lung metastases from bone and soft-tissue sarcomas
R Frakulli, F Salvi, D Balestrini, A Parisi… - Anticancer …, 2015 - ar.iiarjournals.org
Background: The purpose of this study was to evaluate local control and toxicity in a group of
patients treated with stereotactic body radiotherapy (SBRT) for lung metastases (LM) from
bone and soft tissue sarcomas. Patients and Methods: From October 2010 to July 2014,
patients with LM from sarcomas not suitable for surgery were treated with daily cone-beam
computed tomography-guided SBRT. The dose administered ranged from 30 to 60 Gy in 3-8
fractions. Acute and late toxicity were scored according to Common Terminology Criteria for …
patients treated with stereotactic body radiotherapy (SBRT) for lung metastases (LM) from
bone and soft tissue sarcomas. Patients and Methods: From October 2010 to July 2014,
patients with LM from sarcomas not suitable for surgery were treated with daily cone-beam
computed tomography-guided SBRT. The dose administered ranged from 30 to 60 Gy in 3-8
fractions. Acute and late toxicity were scored according to Common Terminology Criteria for …
[引用][C] 3417 Stereotactic radiotherapy in the treatment of lung metastases from bone and soft tissue sarcomas: Final results
F Salvi, R Frakulli, A Longhi, S Ferrari… - European Journal of …, 2015 - infona.pl
3417 Stereotactic radiotherapy in the treatment of lung metastases from bone and soft
tissue sarcomas: Final results … 3417 Stereotactic radiotherapy in the treatment of lung
metastases from bone and soft tissue sarcomas: Final results …
tissue sarcomas: Final results … 3417 Stereotactic radiotherapy in the treatment of lung
metastases from bone and soft tissue sarcomas: Final results …